# HemoSonics LLC clinical trials: 26 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 26 trials with HemoSonics LLC as lead sponsor, 2 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by HemoSonics LLC: 26 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/hemosonics-llc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 26
- Recruiting or not yet: 2
- Read on: November 19, 2026

## Trials

The 25 newest of 26, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| May 19, 2026 | NCT07597278 | Quantra QPlus in Pediatric Cardiovascular Procedures | HemoSonics LLC | Observational | Not yet recruiting | Blood Loss, Surgical | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07597278) |
| March 3, 2026 | NCT07447713 | Reference Range Study for the Quantra System With the QPlus Cartridge in Pediatric Patients | HemoSonics LLC | Observational | Not yet recruiting | Pediatric, Coagulation | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07447713) |
| May 16, 2024 | NCT06415760 | Reference Range Study for the Quantra System With the QStat Cartridge in Obstetric Patients | HemoSonics LLC | Observational | Completed | Obstetric Hemostasis, Coagulation | 129 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06415760) |
| February 13, 2024 | NCT06255496 | QStat Cartridge in Obstetric Patients | HemoSonics LLC | Observational | Completed | Blood Loss Massive, Post Partum Hemorrhage | 296 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06255496) |
| September 6, 2023 | NCT06025708 | Quantra QStat Sample Type Comparison | HemoSonics LLC | Observational | Completed | Coagulation Defect; Bleeding | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06025708) |
| May 25, 2023 | NCT05875987 | Evaluation of the Quantra QStat System in Obstetric Patients | HemoSonics LLC | Observational | Completed | Blood Loss Massive, Post Operative Hemorrhage | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05875987) |
| December 9, 2022 | NCT05645133 | QPlus Pediatric Reference Interval | HemoSonics LLC | Observational | Terminated | Pediatric ALL, Healthy | 93 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05645133) |
| August 15, 2022 | NCT05501730 | Use of the Quantra QPlus Sytem in Cardiac Surgery | HemoSonics LLC | Observational | Completed | Cardiovascular Diseases | 128 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05501730) |
| June 22, 2022 | NCT05426564 | Exploratory Assessment of the Quantra® System in Adult ECMO Patients | HemoSonics LLC | Observational | Completed | Blood Loss, Thrombosis, Extracorporeal Circulation; Complications | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05426564) |
| May 17, 2022 | NCT05376462 | Quantra® System With the QStat® Cartridge in Trauma | HemoSonics LLC | Observational | Terminated | Trauma, Coagulation Defect; Bleeding | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05376462) |
| March 22, 2022 | NCT05290675 | Quantra QPlus Sample Type Comparison | HemoSonics LLC | Observational | Completed | Coagulation Defect; Bleeding | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05290675) |
| July 29, 2020 | NCT04490759 | QStat Pilot Reference Range Study | HemoSonics LLC | Observational | Completed | Coagulation Disorder | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04490759) |
| July 7, 2020 | NCT04460664 | Coagulation Changes Associated With COVID-19 Infection | HemoSonics LLC | Observational | Completed | COVID, Disseminated Intravascular Coagulation, Coagulation Disorder | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04460664) |
| May 13, 2020 | NCT04385953 | QStat in Trauma and Obstetric Hemorrhage | HemoSonics LLC | Observational | Completed | Blood Loss Massive, Trauma, Post Partum Hemorrhage | 22 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04385953) |
| March 18, 2020 | NCT04312958 | Quantra QStat in Trauma and Liver Transplant | HemoSonics LLC | Observational | Completed | Hemorrhage, Trauma, Liver Transplant | 397 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04312958) |
| January 7, 2020 | NCT04219371 | Reference Range Study for the Quantra QStat System | HemoSonics LLC | Observational | Completed | Coagulation Disorder | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04219371) |
| October 4, 2019 | NCT04116385 | Evaluation of the Quantra System in a Surgical Oncological Population | HemoSonics LLC | Observational | Completed | Blood Loss, Surgical | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04116385) |
| October 3, 2019 | NCT04114253 | QStat in Liver Transplant | HemoSonics LLC | Observational | Completed | Blood Loss, Surgical | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04114253) |
| June 17, 2019 | NCT03988465 | HemoSonics - UTMB Cardiac Surgery Study | HemoSonics LLC | Observational | Completed | Blood Loss, Surgical | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03988465) |
| May 2, 2019 | NCT03934983 | Evaluation of the Clinical Performance of the Quantra System With the QStat Cartridge in Trauma | HemoSonics LLC | Observational | Completed | Blood Loss Massive, Trauma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03934983) |
| April 29, 2019 | NCT03931031 | Pre-surgical Evaluation for the Quantra System in Adult Patients Undergoing Cardiac Surgery | HemoSonics LLC | Observational | Completed | Blood Loss, Surgical | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03931031) |
| April 11, 2019 | NCT03912545 | Evaluation of the Clinical Performance of the Quantra System With the QStat Cartridge | HemoSonics LLC | Observational | Completed | Blood Loss Massive, Trauma, Hemorrhage, Postpartum | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03912545) |
| September 26, 2018 | NCT03685097 | Comparison of Two Point-of-care Devices for Viscoelastic Hemostasis Assays | HemoSonics LLC | Observational | Completed | Coagulation Disorder | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03685097) |
| May 15, 2017 | NCT03152461 | Evaluation of the Clinical Performance of the Quantra System With the Quantra Surgical Cartridge | HemoSonics LLC | Observational | Completed | Blood Loss, Surgical | 302 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03152461) |
| May 3, 2017 | NCT03139097 | Reference Range Study for the Quantra Analyzer With the Quantra Surgical Cartridge | HemoSonics LLC | Observational | Completed | Coagulation | 158 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03139097) |

## By phase

| Phase | Trials |
| --- | --- |
| Observational | 26 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 22 |
| Not yet recruiting | 2 |
| Terminated | 2 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Thrombosis | 19 |
| Hemostatic Disorders | 7 |
| Blood Loss, Surgical | 6 |
| Hemorrhage | 5 |
| Wounds and Injuries | 5 |
| Postpartum Hemorrhage | 3 |
| Postoperative Hemorrhage | 1 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 |
| Disseminated Intravascular Coagulation | 1 |
| COVID-19 | 1 |
| Cardiovascular Diseases | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Machinery and tool manufacturers in the United States](https://specstream.ai/data/businesses/machinery-and-tool-manufacturers/united-states)
- [Falafel restaurants in the United States](https://specstream.ai/data/businesses/falafel-restaurants/united-states)
- [Bookkeeping firms in the United States](https://specstream.ai/data/businesses/bookkeeping-firms/united-states)
- [Truck and industrial vehicle companies in the United States](https://specstream.ai/data/businesses/truck-and-industrial-vehicle-companies/united-states)
- [Pharmaceutical products wholesalers in the United States](https://specstream.ai/data/businesses/pharmaceutical-products-wholesalers/united-states)
- [Import and export companies in the United States](https://specstream.ai/data/businesses/import-and-export-companies/united-states)
